Atlas Trials

Influenza Immunization

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Influenza Immunization

RecordFirmDate
Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older (NCT05426174)Sanofi Pasteur, a Sanofi Company2022-06-09
Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and Older (NCT06118151)Sanofi Pasteur, a Sanofi Company2022-04-11
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively (NCT05050318)Sanofi Pasteur, a Sanofi Company2021-09-08
Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine (NCT04969276)Sanofi Pasteur, a Sanofi Company2021-07-16
Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults 60 Years of Age and Older (NCT04498832)Sanofi Pasteur, a Sanofi Company2020-10-21
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively (NCT04551677)Sanofi Pasteur, a Sanofi Company2020-09-16

Track Influenza Immunization automatically

Every clearance here is in the API, with alerts when new ones post.